Launch Results

Quote


















I feel for you and I would expect that's going to happen daily-the drug's an expensive me to with no future It's GSK reps because the VP won't hire any AZ reps since she was terminated. What happened to this industry? Bad management and products-I hope the future isn't like Iroko!
 






PharmaRep7255 said:
I feel for you and I would expect that's going to happen daily-the drug's an expensive me to with no future It's GSK reps because the VP won't hire any AZ reps since she was terminated. What happened to this industry? Bad management and products-I hope the future isn't like Iroko!
Click to expand...

Why would we hire AZ reps, all the ones I have seen are lazy.
 






The reason this job/company will fail is b/c Iroko doesnt have the guts/fortitude to hire their "own" sales force. How is that for a lack of confidence in a TID dosed NSAID? In addition, instead of hiring reps with rapport and relationships with key writers that was cultivated with years of selling to them, they hire young "copier" reps at $50,000 @ year. Yes Mr Manager who interviewed me, you clearly stated this job is a gamble b/c if you dont have a successful launch, Iroko can forget about having the ability/cash on hand to launch the expected "has been" products this Spring! Your strategy is equivalent to entering a 3 legged horse in the Kentucky Derby, the horse can win provided the other 12 horses default or have a major heart attack during the race. Cheaply paid contract reps into todays pharma world where reps will start for 65 - 75K with a reputable pharma company, will never, ever achieve launch expectations, at no fault of their own! Shame on Iroko Management!
 






Anonymous said:
The reason this job/company will fail is b/c Iroko doesnt have the guts/fortitude to hire their "own" sales force. How is that for a lack of confidence in a TID dosed NSAID? In addition, instead of hiring reps with rapport and relationships with key writers that was cultivated with years of selling to them, they hire young "copier" reps at $50,000 @ year. Yes Mr Manager who interviewed me, you clearly stated this job is a gamble b/c if you dont have a successful launch, Iroko can forget about having the ability/cash on hand to launch the expected "has been" products this Spring! Your strategy is equivalent to entering a 3 legged horse in the Kentucky Derby, the horse can win provided the other 12 horses default or have a major heart attack during the race. Cheaply paid contract reps into todays pharma world where reps will start for 65 - 75K with a reputable pharma company, will never, ever achieve launch expectations, at no fault of their own! Shame on Iroko Management!
Click to expand...

At least a "copier sales rep" knows what selling is like and they know how to get the business.
Why do you think most pharm especially Medical Device companies only want B2B reps and will really get their hands on a "copier sales rep", because those reps are "hunters" and not just "order takers".
 






Ok, I'll say it- can inVentiv be any more anal when it comes to expense reporting? Makes you not want to spend anything....hmmmm. Maybe there is a point there. But that won't help. Please- lighten up!
 






Man!! This sure is a negative message board...I have had great success so far. The Doctors get the message and have been writing plenty...no problems at the pharmacy end either...great results with coverage and price as well....lowest price branded NSAID in the market!! Several Doctors have written for 10-15 days and patients gladly paid cash with copay assistance....can't figure out what all the negative hype is about.
 






Ok, are you being a wise ass, joking, insane or lying? So you have "got plenty of scripts" at a cheaper price. This means you followed the patients to the pharmacy, they gladly paid the $25 or higher for the co-pay and it's the cheapest branded NSAID?! 1st define plenty-2nd how is it the lowest branded NSAID on the market & do you know the branded ones-3rd how did you know that the patients gladly paid the high co-pay? Did they call & thank the Dr. for giving them garbage that they can get OTC but puts them at risk for GI bleeding, CV issues and renal failure? Or are you a mentally ill, brainwashed, pathological lier Violating HIPPA laws and selling off-label? Come back to planet earth-calling loser rep, come back to reality
 












Scripts are flying off the shelf, ha! No, this is hard work....3x/day, no data versus generic diclofenac, but trust me it is safer. $4 copay versus $50 copay. It's been a struggle to convince people that this is a better choice that diclofenac and other generic NSAIDS.
 


















Anonymous said:
Scripts are flying off the shelf, ha! No, this is hard work....3x/day, no data versus generic diclofenac, but trust me it is safer. $4 copay versus $50 copay. It's been a struggle to convince people that this is a better choice that diclofenac and other generic NSAIDS.
Click to expand...

Has anyone else tabulated the total NRx's for Competitive branded? Add them all together and see how close to 300 you get. Houston....problem!
 






Anonymous said:
Has anyone else tabulated the total NRx's for Competitive branded? Add them all together and see how close to 300 you get. Houston....problem!
Click to expand...

YES. Wondered if I was alone on this. I know we have something different to offer, but these products are struggling to get 20-25 new Rx's/month. And we are aiming for 300- oh my!!
 






Anonymous said:
YES. Wondered if I was alone on this. I know we have something different to offer, but these products are struggling to get 20-25 new Rx's/month. And we are aiming for 300- oh my!!
Click to expand...

I am also concerned as I look at my geography for these newer branded. Quarter to date of Duexis is like in mid 20's and Zipstor is about same. Wow. Somebody talk me off the ledge please
 






If I was in your position, I would interview with other companies. There's no way this drug is going to survive. Think of it as a temporary job. I reviewed the pipeline & all the company is doing is formulating generic NSAIDS. They couldn't take any other meds & use this "new technology". It puts reps in a bad situation with no credibility-Dr. We have more older NSAID's possibly being launched for the same indication but no head to head studies. Will you prescribe a $5 drug or an expensive 1 with a black box? I don't think so! I would love to hear the physicians response, feedback & Patient's thoughts.
The rep who claims the scrips are flying off the shelf- give some feedback please. All I have heard is negative responses from docs & pharmacists. Please do share
 






Anonymous said:
If I was in your position, I would interview with other companies. There's no way this drug is going to survive. Think of it as a temporary job. I reviewed the pipeline & all the company is doing is formulating generic NSAIDS. They couldn't take any other meds & use this "new technology". It puts reps in a bad situation with no credibility-Dr. We have more older NSAID's possibly being launched for the same indication but no head to head studies. Will you prescribe a $5 drug or an expensive 1 with a black box? I don't think so! I would love to hear the physicians response, feedback & Patient's thoughts.
The rep who claims the scrips are flying off the shelf- give some feedback please. All I have heard is negative responses from docs & pharmacists. Please do share
Click to expand...

Current rep here. I think you are right. Unfortunately.
 






Here's the conversation I am having:

Doctor: Why would I prescribe Zorvolex over generic diclofenac?
Rep: Well it's the lowest possible dose of diclofenac
Doctor: Is it better than generic diclofenac?
Rep: Dunno, but it's the lowest possible dose.
Doctor: Is it safer than generic diclofenac?
Rep: Dunno, but the particles are really small.
Doctor: $10 copay or $50 copay?
Rep: $50
Doctor: BID dosing?
Rep: TID
Doctor: Thank you
 






Top Bottom
Back
Quote